Länder Analysen: Schweiz
| 14.11.25 | Swiss Re Underperform | RBC Capital Markets | |
| 14.11.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 14.11.25 | Richemont Sector Perform | RBC Capital Markets | |
| 14.11.25 | Richemont Buy | Jefferies & Company Inc. | |
| 13.11.25 | Givaudan Overweight | Barclays Capital | |
| 12.11.25 | Roche Hold | Deutsche Bank AG | |
| 12.11.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 12.11.25 | Richemont Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 12.11.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.11.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 11.11.25 | DocMorris Sell | UBS AG | |
| 11.11.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.11.25 | Givaudan Buy | Jefferies & Company Inc. | |
| 10.11.25 | Roche Buy | UBS AG | |
| 10.11.25 | Roche Underperform | Jefferies & Company Inc. | |
| 10.11.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.11.25 | UBS Underweight | Barclays Capital | |
| 07.11.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | Holcim Outperform | Bernstein Research | |
| 06.11.25 | Zurich Insurance Sell | UBS AG | |
| 06.11.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 06.11.25 | UBS Outperform | RBC Capital Markets | |
| 06.11.25 | Roche Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 05.11.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 03.11.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.11.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.11.25 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.25 | Novartis Buy | Deutsche Bank AG | |
| 31.10.25 | UBS Buy | Deutsche Bank AG | |
| 30.10.25 | UBS Buy | Deutsche Bank AG | |
| 30.10.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Novartis Kaufen | DZ BANK | |
| 29.10.25 | Novartis Buy | Deutsche Bank AG | |
| 29.10.25 | Novartis Neutral | UBS AG | |
| 29.10.25 | UBS Outperform | RBC Capital Markets | |
| 29.10.25 | UBS Buy | Jefferies & Company Inc. | |
| 29.10.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 28.10.25 | Marinomed Biotech Kaufen | GBC | |
| 28.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 28.10.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.10.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 27.10.25 | Glencore Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | Roche Outperform | Bernstein Research | |
| 27.10.25 | Novartis Outperform | Bernstein Research | |
| 27.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 27.10.25 | Swiss Re Underweight | Barclays Capital | |